Sponsor content
424 result(s) found, displaying 111 to 120
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: tafenoquine succinate.
-
Prescription medicine decision summaryTGA decision: Jemperli (dostarlimab) is approved to treat patients with recurrent or advanced mismatch repair deficient endometrial cancer.
-
Prescription medicine registrationActive ingredients: dostarlimab.
-
Prescription medicine registrationActive ingredients: mepolizumab.
-
Prescription medicine registrationActive ingredients: mepolizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DOUBLUTS dutasteride 500 microgram and tamsulosin hydrochloride 400 microgram modified release capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROTARIX human rotavirus (live attenuated oral vaccine) oral liquid tube.